MedPath

Pessary in Singleton Gestations With Short Cervix Without Prior Preterm Birth

Phase 3
Completed
Conditions
Preterm Birth
Interventions
Device: Cervical pessary
Registration Number
NCT02716909
Lead Sponsor
Federico II University
Brief Summary

Spontaneous preterm birth (SPTB) remains the number one cause of perinatal mortality in many countries, including the United States. In singleton gestations a short cervical length (CL) on transvaginal ultrasound (TVU) has been shown to be a good predictor of SPTB.

The cervical pessary is a silicone device that has been used to prevent SPTB. The efficacy of cervical pessary has been assessed in several populations including singletons with short CL, unselected twins, twins with a short CL, and triplet pregnancies. Several randomized clinical trials (RCTs) have been published, and several are ongoing. However, no consensus on the use of cervical pessary in pregnancy or guidelines for management have been assessed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
300
Inclusion Criteria
  • 18-50 years of age
  • Singleton pregnancy (limits the participants to female gender)
  • Short cervical length (less than or equal to 25 mm) on second trimester transvaginal ultrasound at 18-23 6/7 weeks gestation
Exclusion Criteria
  • Multiple gestation
  • Prior spontaneous preterm birth 16-36 6/7 weeks
  • Ruptured membranes
  • Lethal fetal structural anomaly
  • Fetal chromosomal abnormality
  • Cerclage in place (or planned placement)
  • Vaginal bleeding
  • Suspicion of chorioamnionitis
  • Ballooning of membranes outside the cervix into the vagina or CL = 0 mm on transvaginal ultrasound
  • Painful regular uterine contractions
  • Placenta previa

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cervical PessaryCervical pessaryThe cervical pessary is a silicone device that has been used to prevent SPTB Pessary will be placed between 18 and 23 6/7 weeks gestation, and will be removed during the 37th week of pregnancy (or earlier, if indicated)
Primary Outcome Measures
NameTimeMethod
Spontaneous preterm birth (SPTB) <34 weeksLess than 34 weeks gestation

Spontaneous preterm delivery less than 34 weeks of gestation

Secondary Outcome Measures
NameTimeMethod
SPTB <37wLess than 37 weeks gestation
SPTB <32wLess than 32 weeks gestation
SPTB <28wLess than 32 weeks gestation
Gestational age at deliveryTime of delivery
Latencytime of delivery

interval from randomization to delivery in days

preterm premature rupture of membranesLess than 34 weeks gestation
Type of deliverytime of delivery

Cesarean delivery, operative vaginal delivery and spontaneous vaginal delivery

Maternal side effectsTime of delivery

Vaginal discharge, bacterial vaginosis

Birth weightTime of delivery
Neonatal deathBetween birth and 28 days of age
perinatal deathfetal death after 20 weeks

either fetal mortality or neonatal death

Composite adverse perinatal outcomeBetween birth and 28 days of age

Includes necrotizing enterocolitis, Intraventricular hemorrhage (grade 3 or higher), respiratory distress syndrome, bronchopulmonary dysplasia (BPD), retinopathy, blood-culture proven sepsis, and neonatal death

ChorioamnionitisTime of delivery
Adminssion to neonatal intensive care unitBetween birth and 28 days of age

Trial Locations

Locations (1)

Gabriele Saccone

🇮🇹

Napoli, Italy

© Copyright 2025. All Rights Reserved by MedPath